GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE
13. November 2023 09:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR
12. Oktober 2023 08:30 ET
|
GlucoTrack, Inc.
Rutherford, NJ, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS
31. August 2023 08:30 ET
|
GlucoTrack, Inc.
Rutherford, NJ, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
GLUCOTRACK ANNOUNCES NEW VP OF MARKETING
28. August 2023 09:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR
25. Juli 2023 09:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ, July 25, 2023 (GLOBE NEWSWIRE) -- - Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock
17. April 2023 09:15 ET
|
GlucoTrack, Inc.
Rutherford, NJ, April 17, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock
13. April 2023 09:22 ET
|
GlucoTrack, Inc.
Rutherford, NJ, April 13, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
GlucoTrack Announces Proposed Underwritten Public Offering of Common Stock
12. April 2023 17:50 ET
|
GlucoTrack, Inc.
Rutherford, NJ, April 12, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
GLUCOTRACK PROVIDES SHAREHOLDER UPDATE
14. März 2023 10:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ, March 14, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
GLUCOTRACK ANNONCE LE RECRUTEMENT DU DR MARK TAPSAK
15. Oktober 2022 09:24 ET
|
GlucoTrack, Inc.
Rutherford, NJ, 15 oct. 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq : GCTK) (« GlucoTrack » ou la « Société »), une société de dispositifs médicaux et de plateformes de santé numériques axée...